Forvis Mazars Wealth Advisors LLC Grows Stock Position in Danaher Corporation $DHR

Key Points

• Forvis Mazars Wealth Advisors LLC increased its holdings in Danaher Corporation by 16.9% in Q1, now owning 12,066 shares valued at approximately $2.47 million.
• Danaher reported quarterly earnings of $1.80 per share, exceeding analysts' estimates of $1.64, with a revenue of $5.94 billion representing a 3.4% increase year-over-year.
• Institutional investors own approximately 79.05% of Danaher's stock, indicating strong institutional interest in the company.

Forvis Mazars Wealth Advisors LLC lifted its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 16.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,066 shares of the conglomerate's stock after buying an additional 1,741 shares during the quarter. Forvis Mazars Wealth Advisors LLC's holdings in Danaher were worth $2,474,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of DHR. Nuveen LLC purchased a new stake in Danaher in the 1st quarter valued at about $833,941,000. GAMMA Investing LLC boosted its holdings in shares of Danaher by 24,958.2% in the first quarter. GAMMA Investing LLC now owns 1,870,847 shares of the conglomerate's stock valued at $383,524,000 after purchasing an additional 1,863,381 shares during the period. Two Sigma Advisers LP increased its holdings in Danaher by 4,248.8% during the 4th quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares during the period. Capital World Investors raised its position in Danaher by 32.7% during the 4th quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock valued at $1,460,215,000 after purchasing an additional 1,566,658 shares in the last quarter. Finally, Invesco Ltd. lifted its holdings in shares of Danaher by 44.5% in the 1st quarter. Invesco Ltd. now owns 4,708,578 shares of the conglomerate's stock worth $965,259,000 after buying an additional 1,450,703 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Analysts Set New Price Targets

Several research firms recently weighed in on DHR. Guggenheim restated a "buy" rating and issued a $250.00 price objective on shares of Danaher in a report on Wednesday, July 23rd. UBS Group reduced their price target on shares of Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a report on Wednesday, July 23rd. Wells Fargo & Company dropped their price objective on shares of Danaher from $210.00 to $205.00 and set an "equal weight" rating on the stock in a research note on Wednesday, July 23rd. Barclays reissued an "overweight" rating and issued a $225.00 price objective (up previously from $215.00) on shares of Danaher in a research note on Tuesday, June 24th. Finally, TD Cowen boosted their price target on Danaher from $240.00 to $248.00 and gave the stock a "buy" rating in a research report on Wednesday, April 23rd. Seventeen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $247.61.

Danaher Stock Down 0.4%

Shares of Danaher stock traded down $0.9530 during trading on Wednesday, reaching $211.2470. The company's stock had a trading volume of 3,302,498 shares, compared to its average volume of 4,235,380. The company has a market cap of $151.26 billion, a price-to-earnings ratio of 44.95, a P/E/G ratio of 2.92 and a beta of 0.73. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.90. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The company has a 50-day simple moving average of $200.33 and a two-hundred day simple moving average of $199.54.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.16. The business had revenue of $5.94 billion during the quarter, compared to analysts' expectations of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business's quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter last year, the company posted $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 earnings per share for the current year.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.